Dipeptidyl peptidase IV inhibitors for the treatment of diabetes

被引：257

作者：

Weber, AE ^{[1
]}

机构：

[1] Merck Res Labs, Rahway, NJ 07065 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2004年 / 47卷 / 17期

关键词：

D O I：

10.1021/jm030628v

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：4135 / 4141

页数：7

共 85 条

[1] Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8 [J].

Abbott, CA ;

Yu, DMT ;

Woollatt, E ;

Sutherland, GR ;

McCaughan, GW ;

Gorrell, MD .

EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (20) :6140-6150

[2] Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice [J].

Ahrén, B ;

Holst, JJ ;

Mårtensson, H ;

Balkan, B .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 404 (1-2) :239-245

[3]

Ahren B, 2003, DIABETES, V52, pA15

[4] Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes [J].

Ahrén, B ;

Simonsson, E ;

Larsson, H ;

Landin-Olsson, M ;

Torgeirsson, H ;

Jansson, PA ;

Sandqvist, M ;

Båvenholm, P ;

Efendic, S ;

Eriksson, JW ;

Dickinson, S ;

Holmes, D .

DIABETES CARE, 2002, 25 (05) :869-875

[5] 4-cyanothiazolidides as very potent, stable inhibitors of dipeptidyl peptidase IV [J].

Ashworth, DM ;

Atrash, B ;

Baker, GR ;

Baxter, AJ ;

Jenkins, PD ;

Jones, DM ;

Szelke, M .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (22) :2745-2748

[6] 2-cyanopyrrolidides as potent, stable inhibitors of dipeptidyl peptidase IV [J].

Ashworth, DM ;

Atrash, B ;

Baker, GR ;

Baxter, AJ ;

Jenkins, PD ;

Jones, DM ;

Szelke, M .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (10) :1163-1166

[7] Dipeptidyl peptidase IV inhibitors as new therapeutic agents for the treatment of Type 2 diabetes [J].

Augustyns, K ;

Van der Veken, P ;

Senten, K ;

Haemers, A .

EXPERT OPINION ON THERAPEUTIC PATENTS, 2003, 13 (04) :499-510

[8]

Augustyns K, 1999, CURR MED CHEM, V6, P311

[9] Pyrrolidides: Synthesis and structure-activity relationship as inhibitors of dipeptidyl peptidase IV [J].

Augustyns, KJL ;

Lambeir, AM ;

Borloo, M ;

DeMeester, I ;

Vedernikova, I ;

Vanhoof, G ;

Hendriks, D ;

Scharpe, S ;

Haemers, A .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1997, 32 (04) :301-309

[10] Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves oral glucose tolerance in obese Zucker rats [J].

Balkan, B ;

Kwasnik, L ;

Miserendino, R ;

Holst, JJ ;

Li, X .

DIABETOLOGIA, 1999, 42 (11) :1324-1331

← 1 2 3 4 5 6 7 8 9 →